Test May Suggest Tysabri for More MS Patients (CME/CE)

COPENHAGEN (MedPage Today) -- A blood test for L-selectin expression on circulating immune cells may identify multiple sclerosis patients who could safely receive natalizumab (Tysabri) despite past exposure to the JC virus, a small study suggested.
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news